More GLP-1s Are Coming—But Are We Ready?
My AccountFIND A DOCTORFaceAdult AcneAnti-AgingAntioxidantsCelebrityChronic Skin ConditionsEyeHydrationHyperpigmentationMakeupMale Skin CarePeelsPre-Event PrepRetinoidsSensitive SkinSkin CareSkin HealthSmileSun CareTreatmentsAnti-WrinkleFillersMicroneedlingNeurotoxinsPost-Procedure Skin CareRegenerative AestheticsBodyBody SculptingBreastsButtsCelluliteFind a DoctorHair RemovalHands + NailsLegsPregnancyHairBond RepairCelebrity HairDry HairFrizzy HairGray HairHair ColorHair GrowthHair RepairScalp HealthTips + TutorialsAwardsNB100 Awards16th Annual Beauty Awards2025 NewBeauty Readers’ Choice AwardsShoppingBeautyReportGift GuidesNewBeauty StorefrontProduct ReviewsWellnessFitnessGLP-1sHealthMenopauseAbout UsTESTTUBEFaceView All FaceAdult AcneAnti-AgingAntioxidantsCelebrityChronic Skin ConditionsEyeHydrationHyperpigmentationMakeupMale Skin CarePeelsPre-Event PrepRetinoidsSensitive SkinSkin CareSkin HealthSmileSun CareTreatmentsView All TreatmentsAnti-WrinkleFillersMicroneedlingNeurotoxinsPost-Procedure Skin CareRegenerative AestheticsBodyView All BodyBody SculptingBreastsButtsCelluliteFind a DoctorHair RemovalHands + NailsLegsPregnancyHairView All HairBond RepairCelebrity HairDry HairFrizzy HairGray HairHair ColorHair GrowthHair RepairScalp HealthTips + TutorialsAwardsView All AwardsNB100 Awards16th Annual Beauty Awards2025 NewBeauty Readers’ Choice AwardsShoppingView All ShoppingBeautyReportGift GuidesNewBeauty StorefrontProduct ReviewsWellnessView All WellnessFitnessGLP-1sHealthMenopauseAbout UsLoading…FIND A DOCTORTESTTUBE Advertisement Home›GLP-1s More GLP-1s Are Coming—But Are We Ready? The latest GLP-1 news from the American Diabetes Association scientific sessions. The American Diabetes Association's annual scientific sessions 2026 confirmed what many of us have been anticipating for years. We’re entering a new era of obesity medicine: triple agonists, oral GLP-1s, monthly injections and therapies targeting obesity, diabetes and fatty liver disease simultaneously. This is exciting. But it also means treatment is becoming more complex. The question is no longer, “Which medication causes the most weight loss?” The question is: How do we use these medications safely and effectively while preserving muscle, improving body composition and helping patients achieve long-term success?That’s exactly why I wrote Weightless and why I built WeightlessAI, my clinical guidance platform. The more options we have, the more important education becomes—for BOTH clinicians and patients. The medications are evolving. The way we guide patients must evolve too. But most importantly: sophisticated medications require sophisticated guidance. Full Stop.